Stanford University, funded by the US Department of Defense (DOD), is running a trial of ibogaine for military veterans with PTSD and substance use disorder. By Q3 2026 (summer/fall), they will publish early results showing whether ibogaine actually helps these veterans. This matters because veterans' groups and their congressional allies are waiting for this data to push for policy change — ibogaine is currently illegal in the US.
Stanford's program has active DOD funding and strong veteran advocacy pressure creating a predictable data-release-to-Capitol-Hill pipeline. Preliminary data release at this trial stage is standard, and congressional allies have publicly signaled they are waiting for this hook to stage hearings. Resolvable by checking trial publications and congressional records.